Superhuman Fund is an early-stage venture fund focused on human enhancement and frontier biotechnology, investing in longevity, gene editing, brain-computer interfaces, peptides, and AI-driven biotech. Founded by Michal Kubis, the fund backs builders accelerating the future of human enhancement to keep humans relevant in the age of AI.
33% of their portfolio is in Fintech. Their most common stage is seed (50% of deals). Average disclosed round size is $6.5M (across 4 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Seed
Last 12 Mo
1
Team
MK
Michal Kubis
Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 SiftHub | Seed | $5.5M | Jan 2026 |
 Stilt | Series A | $14M | Mar 2022 |
 Simplified | Seed | $2.2M | Jun 2021 |
 BukuWarung | Unknown | — | Sep 2020 |
 NexHealth | Series A | — | Jun 2020 |
 Command E | Seed | $4.3M | May 2020 |
Top Co-Investors
Uber Investments2 shared
Craft Ventures2 shared
DST Global1 shared
Plaid1 shared
20VC1 shared
Soma Capital1 shared
BOND1 shared
Tinder1 shared
Adobe1 shared
Bain Capital Ventures1 shared
Abstract Ventures1 shared
Amplify Partners1 shared
Upside Partnership1 shared
Shrug Capital1 shared
Earl Grey Capital1 shared
8-Bit Capital1 shared
Form Ventures1 shared
GFR Fund1 shared
Ribbit Capital1 shared
MyAsiaVC1 shared
Last updated: 8 September 2026